Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models

Biomaterials

Volumn 35, Issue 7, 2014, Pages 2302-2311

  Ryu, Ju Hee ^a,b   Na, Jin Hee ^a   Ko, Ho Kyung ^a   You, Dong Gil ^a,c   Park, Subin ^a,c   Jun, Eunsung ^a,d   Yeom, Ho Jun ^a,e   Seo, Deok Ho ^a,e   Park, Jae Hyung ^c   Jeong, Seo Young ^e   Kim, In San ^a,d   Kim, Byung Soo ^b   Kwon, Ick Chan ^a,f   Choi, Kuiwon ^a   Kim, Kwangmeyung ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

^e Kyung Hee University   (South Korea)

^f Korea University   (South Korea)

Author keywords

Cathepsin B; Fluorescence; Metastasis; Metastatic mouse model; Molecular imaging

Indexed keywords

CATHEPSIN B; FLUORESCENCE INTENSITIES; FLUORESCENCE SIGNALS; METASTASIS; MOUSE MODELS; PHYSIOLOGICAL CONDITION; SPHERICAL NANOPARTICLES; WESTERN-BLOT ANALYSIS;

DIAGNOSIS; FLUORESCENCE; MAMMALS; MOLECULAR IMAGING; NANOPARTICLES; NANOPROBES; PEPTIDES; PROBES;

PATHOLOGY;

CATHEPSIN B; CHITOSAN; NANOPARTICLE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; MOLECULAR IMAGING; MOUSE; NANOPROBE; NON INVASIVE PROCEDURE; NONHUMAN; NONPHOTOCHEMICAL QUENCHING; PERITONEUM METASTASIS; PRIORITY JOURNAL; WESTERN BLOTTING;

CATHEPSIN B; FLUORESCENCE; METASTASIS; METASTATIC MOUSE MODEL; MOLECULAR IMAGING;

CATHEPSIN B; CELL LINE, TUMOR; CHITOSAN; COLONIC NEOPLASMS; FLUORESCENT DYES; HUMANS; MODELS, BIOLOGICAL; NANOSTRUCTURES; NEOPLASM METASTASIS; OPTICAL IMAGING;

EID: 84891372016     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.080     Document Type: Article

References (38)

1. Sporn M.B. The war on cancer. Lancet 1996, 347:1377-1381.
2. Chaffer C.L., Weinberg R.A. Aperspective on cancer cell metastasis. Science 2011, 331:1559-1564.
3. McCann T.E., Kosaka N., Turkbey B., Mitsunaga M., Choyke P.L., Kobayashi H. Molecular imaging of tumor invasion and metastases: the role of MRI. NMR Biomed 2011, 24:561-568.
4. Sloane B.F., Yan S., Podgorski I., Linebaugh B.E., Cher M.L., Mai J., et al. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin Cancer Biol 2005, 15:149-157.
5. Sloane B.F., Rozhin J., Johnson K., Taylor H., Crissman J.D., Honn K.V. Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci U S A 1986, 83:2483-2487.
6. Van Noorden C.J., Jonges T.G., Meade-Tollin L.C., Smith R.E., Koehler A. Invivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants. Br J Cancer 2000, 82:931-936.
7. Mohamed M.M., Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006, 6:764-775.
8. Ryu J.H., Kim S.A., Koo H., Yhee J.Y., Lee A., Na J.H., et al. Cathepsin B-sensitive nanoprobe for invivo tumor diagnosis. JMater Chem 2011, 21:17631-17634.
9. Na J.H., Koo H., Lee S., Min K.H., Park K., Yoo H., et al. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials 2011, 32:5252-5261.
10. Lavilla-Alonso S., Abo-Ramadan U., Halavaara J., Escutenaire S., Tatlisumak T., Saksela K., et al. Optimized mouse model for the imaging of tumor metastasis upon experimental therapy. PLoS One 2011, 6:e26810.
11. Osawa Y., Suetsugu A., Matsushima-Nishiwaki R., Yasuda I., Saibara T., Moriwaki H., et al. Liver acid sphingomyelinase inhibits growth of metastatic colon cancer. JClin Invest 2013, 123:834-843.
12. Park K., Ki Lee S., Hyun Son D., Ah Park S., Kim K., Won Chang H., et al. The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative. Biomaterials 2007, 28:2667-2676.
13. Mori A., Arii S., Furutani M., Mizumoto M., Uchida S., Furuyama H., et al. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes. Gene Ther 2000, 7:1027-1033.
14. Nayak T.K., Garmestani K., Milenic D.E., Brechbiel M.W. PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled Panitumumab. JNucl Med 2012, 53:113-120.
15. Krueger S., Kalinski T., Wolf H., Kellner U., Roessner A. Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture-regulation of cathepsin B expression and invasiveness. Cancer Lett 2005, 223:313-322.
16. Xie B.W., Mol I.M., Keereweer S., van Beek E.R., Que I., Snoeks T.J., et al. Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model. PLoS One 2012, 7:e31875.
17. Sloane B.F., Honn K.V., Sadler J.G., Turner W.A., Kimpson J.J., Taylor J.D. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res 1982, 42:980-986.
18. Kim M., Egan C., Alain T., Urbanski S.J., Lee P.W., Forsyth P.A., et al. Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells. Oncogene 2007, 26:4124-4134.
19. Yang Y., Aw J., Chen K., Liu F., Padmanabhan P., Hou Y., et al. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging. Chem Asian J 2011, 6:1381-1389.
20. Zhang Q., Bindokas V., Shen J., Fan H., Hoffman R.M., Xing H.R. Time-course imaging of therapeutic functional tumor vascular normalization by antiangiogenic agents. Mol Cancer Ther 2011, 10:1173-1184.
21. Ntziachristos V., Tung C.-H., Bremer C., Weissleder R. Fluorescence molecular tomography resolves protease activity invivo. Nat Med 2002, 8:757-761.
22. Zhao L., Lee V.K., Yoo S.S., Dai G., Intes X. The integration of 3-D cell printing and mesoscopic fluorescence molecular tomography of vascular constructs within thick hydrogel scaffolds. Biomaterials 2012, 33:5325-5332.
23. Coulibaly S., Schwihla H., Abrahamson M., Albini A., Cerni C., Clark J.L., et al. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 1999, 83:526-531.
24. Hazen L.G., Bleeker F.E., Lauritzen B., Bahns S., Song J., Jonker A., et al. Comparative localization of cathepsin B protein and activity in colorectal cancer. JHistochem Cytochem 2000, 48:1421-1430.
25. Withana N.P., Blum G., Sameni M., Slaney C., Anbalagan A., Olive M.B., et al. Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Res 2012, 72:1199-1209.
26. Hama Y., Urano Y., Koyama Y., Kamiya M., Bernardo M., Paik R.S., et al. Invivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent. Neoplasia 2006, 8:607-612.
27. Na J.H., Lee S.-Y., Lee S., Koo H., Min K.H., Jeong S.Y., et al. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency. JControl Release 2012, 163:2-9.
28. Gong P., Shi B., Zheng M., Wang B., Zhang P., Hu D., et al. PEI protected aptamer molecular probes for contrast-enhanced invivo cancer imaging. Biomaterials 2012, 33:7810-7817.
29. Ryu J.H., Shin J.-Y., Kim S.A., Kang S.-W., Kim H., Kang S., et al. Non-invasive optical imaging of matrix metalloproteinase activity with albumin-based fluorogenic nanoprobes during angiogenesis in a mouse hindlimb ischemia model. Biomaterials 2013, 34:6871-6881.
30. Khanna C., Hunter K. Modeling metastasis invivo. Carcinogenesis 2005, 26:513-523.
31. Francia G., Cruz-Munoz W., Man S., Xu P., Kerbel R.S. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 2011, 11:135-141.
32. McEarchern J.A., Kobie J.J., Mack V., Wu R.S., Meade-Tollin L., Arteaga C.L., et al. Invasion and metastasis of a mammary tumor involves TGF-β signaling. Int J Cancer 2001, 91:76-82.
33. Kim J.-B., Urban K., Cochran E., Lee S., Ang A., Rice B., et al. Non-invasive detection of a small number of bioluminescent cancer cells invivo. PLoS One 2010, 5:e9364.
34. Poste G., Doll J., Hart I.R., Fidler I.J. Invitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 1980, 40:1636-1644.
35. Liu J., Tan Y., Zhang H., Zhang Y., Xu P., Chen J., et al. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater 2012, 11:734-741.
36. Zijlstra A., Mellor R., Panzarella G., Aimes R.T., Hooper J.D., Marchenko N.D., et al. Aquantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res 2002, 62:7083-7092.
37. Stoletov K., Montel V., Lester R.D., Gonias S.L., Klemke R. High-resolution imaging of the dynamic tumor cell-vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A 2007, 104:17406-17411.
38. Paris S., Sesboüé R. Metastasis models: the green fluorescent revolution?. Carcinogenesis 2004, 25:2285-2292.